Regenerative Medicine - Global Market Trends

Regenerative Medicine - Global Market Trends

Science of regeneration offers huge opportunities for the betterment of mankind. Regenerative medicine offers therapeutic opportunities where there are presently no treatments. The regenerative medicine industry is in nascent stages in terms of commercial applications. To date, most of the advances made in regenerative medicine are confined to bone and joint applications, and to an extent regeneration of blood. Even in bone and joint applications the advances are limited to in-vitro development. Huge opportunity for regenerative medicine exists in in-vivo development. It would not be long before regenerative therapies for chronic conditions such as diabetes are realized.

These and other market data and trends are presented in "Regenerative Medicine: Global Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

REGENERATIVE MEDICINE BMR-1036


CONTENTS


1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 4
Regenerative Medicine - the Past, the Present, & the Future 4
Another Revolution in the Making? 5
Conventional Chemical Medicine Vs Regenerative Medicine 6
The Need for Regenerative Medicine 6
Regenerative Medicine Throws in Several New Therapies 7
What’s in Store? 7
Regenerative Medicine to Arrest Ageing? 7
Thriving on an Aging World Population 8
Faster Healing Process 8
Regenerative Medicine to Overcome Donor Organs Shortage 8
Possible Scenarios 9
Stem Cell Research - Not Just Another Medical Advancement 9
Key Issues at Play 10
Market Potential 10
Regenerative Medicine in Bone and Joint Applications 10
US Corners a Lion’s Share 10
Growth Drivers 11
Trends & Issues 11
Biomaterials Sought After in Regenerative Medicine 11
Upbeat Market for Cell-based Tissue Engineering 12
Progenitor Cell Therapy to Witness No Holds Barred Growth 12
Players Embrace Automation in Production Facilities 13
Contract Manufacturing, a Growing Sector 13
Investors Wary of Funding Regenerative Medicine 14
Regenerative Medicine Field Lags Behind due to Segregated Focus 14
Challenges to Be Encountered by Tissue Engineering Companies 15
Activity in the Field of Regenerative Medicine 15

3. PRODUCTS FACTS 16

4. REGULATORY ENVIRONMENT 17
Regulatory Norms Governing ES Cell Research 17
Legality of ES Cell Use in Major Developed Nations 17

5. CORPORATE DEVELOPMENTS 17
Cytori and Green Hospital Supply Ink Strategic Equity Deal 17
RNL Bio Establishes Research Unit at Newcastle University 18
Tengion Begins Third Phase II Clinical Trial of Neo-Bladder
Augment™ 18
Organogenesis Signs MoU with NTEC 18
BioTime Establishes New Stem Cell Division 19
Integra Life Sciences Acquires IsoTis, Inc. 19
NovaThera and Gamida Join Hands for Developing Cell
Therapeutics for Lung- Regeneration 20
Tigenix Teams Up with Fidea to Develop Biological Joint Implants 20
Scotland Plans to Build Center for Regenerative Medicine in
Edinburgh 21
Celprogen Launches 11 Cancer Stem Cells 21

6. MAJOR PLAYERS 21
BioVest International, Inc. (US) 21
Curis, Inc. (US) 21
Cytori Therapeutics, Inc. (US) 22
DeveloGen AG (Germany) 22
Forticell Bioscience, Inc. (US) 22
Geron Corporation (US) 22
Human Genome Sciences, Inc. (US) 23
IsoTis, Inc. 23
Kiadis Pharma B.V. 23
LifeCell Corporation (US) 23
Osiris Therapeutics, Inc. (US) 23
Tepha Inc. (US) 24
TiGenix N.V. (Belgium) 24

7. GLOBAL MARKET ANALYTICS 25

8. THE UNITED STATES 25
Regenerative Medicine in Bone and Joint Applications 25
Regenerative Therapy - Best Fit for Joint Problems 26
Millions of American Patients Put their Hope in Stem Cell
Research 27
US Witnesses Mixed Response for Government Support for hESC
Research 27
CBI’s Human Tissue Products for Treating Liver Failure and
Diabetes 28
Market for Liver and Pancreas Transplantation 29
Implantable Regenerative Products Take Over Sports Medicine 29

9. JAPAN 30
Research Activity in Regenerative Medicine Field 30
More Companies Eye the Regenerative Medicine Potential 31
Competition Heats up Behind Closed Doors 31
Japanese Firms Need to Catch Up with US and European Competitors 32
Science Ministry Rolls Out Regenerative Medicine Project 32
Regenerative Medicine Exempted from Ban on Human Cloning 32

10. EUROPE 33

11. REVIEW OF REGENERATIVE MEDICINE IN OTHER GEOGRAPHIC MARKETS 34

a. Canada 34
University of Toronto - Spearheading Regenerative Medicine
Research 34

b. Asia-Pacific 35
China 35
Substantial Government Support 35
India 35
CSIR- Leading the way in Regenerative Medicine Research 35
High Growth Opportunities 35
South Korea 36
Malaysia 36
Singapore 36

c. Rest of World 37
Argentina 37
South Africa 38


EXHIBITS

Table 1: Global Market for Regenerative Medicine Products in
Bone and Joint Applications by Region for the Period 2007-2015
(Sales in US$ Million)

Table 2: Percentage Breakdown of Global Market for
Regenerative Medicine Products for Bone and Joint Applications
by Region for the Years 2008 & 2012

Table 3: Prevalence of Various Diseases in the US

Table 4: The US Market for Regenerative Medicine Products in
Bone and Joint Applications Market: 2007-2015 (Sales in US$
Million)

Table 5: Japanese Market for Regenerative Medicine Products in
Bone and Joint Applications Market: 2007-2015 (Sales in US$
Million)

Table 6: European Market for Regenerative Medicine Products in
Bone and Joint Applications Market: 2007-2015 (Sales in US$
Million)


COMPANIES PROFILED